Lupus erythematosus, systemic Trials in Boston, United States
Conditions / Lupus erythematosus, systemic / Boston, United States
Clinical trials for Lupus erythematosus, systemic investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03161483 | A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus | COMPLETED | PHASE2 |
| NCT07015983 | A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE) | RECRUITING | — |
| NCT00624338 | Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) | COMPLETED | PHASE2/PHASE3 |
| NCT04961567 | A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01582880 | Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis | COMPLETED | PHASE1/PHASE2 |
| NCT02034344 | A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers | COMPLETED | — |
| NCT00137969 | A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus | COMPLETED | PHASE2/PHASE3 |
| NCT00071487 | Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) | COMPLETED | PHASE2 |
| NCT06581198 | A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) | RECRUITING | PHASE2 |
| NCT01405196 | Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus | COMPLETED | PHASE2 |